Bergamot Cholesterol Support With Resveratrol
Bergamot Cholesterol Support With Resveratrol is a longevity and NAD+ category supplement from Reserveage, formulated to potentially support cardiovascular health. Each serving contains 500 mg of Bergamonte Citrus Bergamot Polyphenolic extract and 150 mg of a Pro-Longevity Factors Blend, which includes organic French and Muscadine whole red grape. This product has an N+ Score of 50, earning an 'F' grade, placing it in the below-average tier. Notably, no ingredients are identified as being at clinical doses, and its formula completeness score is 0, suggesting a narrow focus or lack of comprehensive formulation. While label transparency is 60%, the overall scoring indicates areas for improvement in ingredient efficacy and comprehensive support. This supplement may appeal to those interested in specific plant-based compounds for general wellness support.
About This Product
Bergamot Cholesterol Support With Resveratrol by Reserveage is a longevity & nad+ supplement containing 5 active ingredients. It has earned an N+ Score of 50/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Pro-Longevity Factors Blend | 150.000 mg | N/A |
| Bergamonte Citrus Bergamot Polyphenolic extract | 500.000 mg | N/A |
| organic French whole Red Wine Grape | — | N/A |
| certified organic Muscadine whole Red Grape | — | N/A |
| Oliveolive (Olea europaea) (fruit) extract | 100.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.